EUVIMEDEUVIMED entdecken
Crossref

Effects of GM1 ganglioside and its derivatives on ETI-rescued F508del-CFTR maturation and host-pathogen interactions in cystic fibrosis bronchial cells

Dorina Dobi iD, Alessandro Rimessi iD, Nicoletta Loberto iD, Laura Mauri iD, Rosaria Bassi iD, Elena Chiricozzi iD, Debora Olioso iD, Giulia Pellielo iD, Paolo Pinton iD, Valentino Bezzerri iD, Giulio Cabrini iD, Giuseppe Lippi iD und 3 weitere

Glycoconjugate Journal · 2025

DOI: 10.1007/s10719-025-10191-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glycoconjugate Journal, 2025. Verfasst von Dorina Dobi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology and Translational Medicine, University of Milano, Milano, Italy. Hauptthemen laut MEDLINE: Cystic Fibrosis Transmembrane Conductance Regulator, Cystic Fibrosis, G(M1) Ganglioside, Bronchi. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Ministry of education, Ministry of the University and research, Italy, Fondazione AIRC per la ricerca sul cancro ETS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic Fibrosis (CF), a life-threatening hereditary disease, arises from mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene, which encodes a chloride-conducting channel widely expressed in epithelial cells. The most common mutation, F508del, causes CFTR misfolding, premature degradation, and impaired mucociliary clearance, leading to recurrent respiratory infections and inflammation. The triple combination therapy with Elexacaftor, Tezacaftor, and Ivacaftor (ETI) has revolutionized CF management by partially restoring mutated CFTR function. However, enhancing CFTR rescue and stabilizing host immune responses remain critical challenges. In airway epithelial cells, CFTR interacts with proteins and lipids in macromolecular complexes that influence its stability. Among these, the ganglioside GM1 plays a key role in modulating plasma membrane protein dynamics, including CFTR. This study investigates the effects of exogenous GM1 supplementation as an adjuvant to ETI treatment. Our results demonstrate that GM1 enhances F508del-CFTR maturation and stability, even under Pseudomonas aeruginosa infection, which typically suppresses CFTR expression and function. Furthermore, GM1 restores xenophagic activity in bronchial epithelial cells, improving host defence mechanisms against the bacteria. These findings underscore the therapeutic potential of GM1 and its analogues in optimizing the plasma membrane environment for CFTR correction, suggesting that by enhancing the efficacy of CFTR modulators, GM1 could pave the way for innovative approaches to improve CF management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic Fibrosis Transmembrane Conductance RegulatorCystic FibrosisG(M1) GangliosideBronchiHost-Pathogen InteractionsQuinolonesAminophenolsHumansEpithelial CellsBenzodioxolesPseudomonas aeruginosaCell LineIndoles

Stichwörter der Autor:innen

Pseudomonas AeruginosaCystic fibrosisGM1GangliosidesInfectionsLipids rafts

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorG(M1) GangliosideCFTR protein, humanQuinolonesAminophenolsBenzodioxolesivacaftorIndoles

Autor:innen und Institutionen

  • Department of Medical Biotechnology and Translational Medicine, University of Milano, Milano, Italy.
  • Center of Research for Innovative Therapies in Cystic Fibrosis, University of Ferrara, Ferrara, Italy.
  • Department of Medical Sciences, Section of Experimental Medicine, Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara, Italy.
  • Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy.
  • Biomedical Research Center, Kansai Medical University, Osaka, Japan.
  • Cystic Fibrosis Center of Verona, University Hospital of Verona, Verona, Italy.

ORCID-Profile: Dorina Dobi, Alessandro Rimessi, Nicoletta Loberto, Laura Mauri, Rosaria Bassi, Elena Chiricozzi, Debora Olioso, Giulia Pellielo, Paolo Pinton, Valentino Bezzerri, Giulio Cabrini, Giuseppe Lippi, Anna Tamanini, Giulia Lunghi, Massimo Aureli

Förderung

  • Ministry of education
  • Ministry of the University and research, Italy
  • Fondazione AIRC per la ricerca sul cancro ETS
  • Fondazione per la Ricerca sulla Fibrosi Cistica

Zitieren

APA

Dobi, D., Rimessi, A., Loberto, N., Mauri, L., Bassi, R., Chiricozzi, E., Olioso, D., Pellielo, G., Pinton, P., Bezzerri, V., Cabrini, G., Lippi, G., Tamanini, A., Lunghi, G., & Aureli, M. (2025). Effects of GM1 ganglioside and its derivatives on ETI-rescued F508del-CFTR maturation and host-pathogen interactions in cystic fibrosis bronchial cells. Glycoconjugate Journal. https://doi.org/10.1007/s10719-025-10191-0

Vancouver

Dobi D, Rimessi A, Loberto N, Mauri L, Bassi R, Chiricozzi E, et al. Effects of GM1 ganglioside and its derivatives on ETI-rescued F508del-CFTR maturation and host-pathogen interactions in cystic fibrosis bronchial cells. Glycoconjugate Journal. 2025. doi:10.1007/s10719-025-10191-0

BibTeX
@article{Dobi2025,
  author = {Dobi, Dorina and Rimessi, Alessandro and Loberto, Nicoletta and Mauri, Laura and Bassi, Rosaria and Chiricozzi, Elena and Olioso, Debora and Pellielo, Giulia and Pinton, Paolo and Bezzerri, Valentino and Cabrini, Giulio and Lippi, Giuseppe and Tamanini, Anna and Lunghi, Giulia and Aureli, Massimo},
  title = {Effects of GM1 ganglioside and its derivatives on ETI-rescued F508del-CFTR maturation and host-pathogen interactions in cystic fibrosis bronchial cells},
  journal = {Glycoconjugate Journal},
  year = {2025},
  doi = {10.1007/s10719-025-10191-0}
}
Kostenlos starten →